"Smart Drugs" - New Innovations in Drug Technology

What are "smart drugs?" Should the federal government have an increased role in the development and distribution of pharmaceuticals? Do tomorrow's pharmaceuticals hinge on today's stem cell research? Will the next wave of drugs focus on curing certain diseases within certain populations?

These topics and other issues focused on new innovations in the drug and pharmaceutical industry are discussed this Sunday on Technogenesis®, a TV program produced by Stevens Institute of Technology, in cooperation with cn8, the Comcast Network.

Featured guests on the program include former New Jersey Congressman and president of the HealthCare Institute of New Jersey, Robert Franks, and former commissioner of health and senior services for the state of New Jersey and vice president of Aventis Pasteur, Christine Grant.

The Technogenesis program, "Smart Drugs: New Innovations in Drug Technology" airs at 7:00 p.m., on cn8, the Comcast Network, each of the following Sundays in the New York City, Philadelphia and Baltimore regions: Dec. 30, Jan. 13, Jan. 27, Feb. 10 and Feb. 24. The program will also appear at various times on the local Comcast outlets in Prince William and Fairfax counties, VA, as well as Prince George's County, MD. Please check for local listings.

In August of this year, Robert Franks was appointed president of the HealthCare Institute of New Jersey - an association of 17 research-based pharmaceutical and medical technology companies in New Jersey. Before joining the HealthCare Institute of New Jersey, Franks served 4 consecutive terms as a U.S. Congressman for New Jersey's 7th district, presiding or sitting on numerous congressional committees and task forces.

Christine Grant is a nationally recognized expert in healthcare, pharmaceutical financing and public health crises. As a vice president at Aventis Pasteur, Grant works on a number of domestic and global issues including the creation of collaborative systems to manage a global or pandemic influenza outbreak. Prior to Aventis, Grant served as New Jersey's Commissioner of Health and Senior Services and was an executive at numerous companies in the healthcare industry.

Co-produced by Stevens and Comcast, the half-hour Technogenesis programs feature government, research and industry leaders discussing some of the most challenging real-world issues facing science and technology today.

This week, expert immunologist and professor at the University of Medicine and Dentistry of New Jersey, Dr. Elizabeth Raveche, served as a special guest co-host of the program, along with veteran TV journalist Steve Taylor. Each Technogenesis program includes two or more special guests from the areas of science, technology, government, education, business or industry.

The Comcast Network is one of the nation's largest regional cable networks reaching close to 4 million households in New Jersey, Pennsylvania, Delaware and Maryland.

About Stevens Institute of Technology

Founded in 1870, Stevens Institute of Technology is one of the leading technological universities in the world dedicated to learning and research. Through its broad-based curricula, nurturing of creative inventiveness, and cross disciplinary research, the Institute is at the forefront of global challenges in engineering, science, and technology management. Partnerships and collaboration between, and among, business, industry, government and other universities contribute to the enriched environment of the Institute. A new model for technology commercialization in academe, known as Technogenesis®, involves external partners in launching business enterprises to create broad opportunities and shared value.

Stevens offers baccalaureates, master’s and doctoral degrees in engineering, science, computer science and management, in addition to a baccalaureate degree in the humanities and liberal arts, and in business and technology. The university has a total enrollment of 2,150 undergraduate and 3,500 graduate students, with about 250 full-time faculty. Stevens’ graduate programs have attracted international participation from China, India, Southeast Asia, Europe and Latin America. Additional information may be obtained from its web page at www.stevens.edu.  

For the latest news about Stevens, please visit StevensNewsService.com.